Hydroxyzine Pamoate Capsule
Product Images NDC 43063-406

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Pamoate (NDC 43063-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (43063406)

Label for hydroxyzine pamoate 25 mg oral capsules, containing 15 capsules per package. The label includes warnings about drowsiness, dosage instructions, and storage information. The product is labeled by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, with NDC 43063-406-15. Expiration date is 03/2024, lot number C22G01.*

FDA Label Image

Hypam 01

Chemical structure diagram of hydroxyzine pamoate, showing its molecular components including aromatic rings, hydroxyl groups, and ether linkages. The structure depicts the chemical composition of the active ingredient hydroxyzine pamoate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.